Supplier profile
Hexal AG
Every public-sector award we hold for this supplier, across Germany, from 20 Apr 2009 to 25 Jul 2026.
Awards won
350
all time
Attributed value
€1.2m
312 shared, unvalued
Buyers
56
public bodies
Active
2009–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| DAK-Gesundheit | 53 | not attributable |
| GWQ ServicePlus AG | 42 | not attributable |
| Techniker Krankenkasse | 41 | €2 |
| IKK classic | 28 | €878k |
| AOK Nordost – Die Gesundheitskasse | 22 | not attributable |
| AOK Baden-Württemberg | 15 | not attributable |
| spectrumK GmbH | 14 | not attributable |
| AOK Bayern – Die Gesundheitskasse | 13 | not attributable |
| Deutsche Rentenversicherung Knappschaft-Bahn-See (KBS) | 12 | not attributable |
| Vergabestelle der AOK – Rheinland-Pfalz/Saarland – Die Gesundheitskasse | 12 | not attributable |
What they win
Awards
Showing 26–50 of 350 awards we hold
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Dimethylfumarat (ausschl 240mg, N3), ATC L04AX07 f.d.Z. 01.10.25-30.09.27 (zzgl.Verlängerung 1x12 Mon) ↗DAK-Gesundheitshared awardawarded 2 Oct 2025
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Teriflunomid, ATC L04AK02 für die Zeit 01.10.2025 - 31.12.2025 (zzgl. Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 1 Oct 2025
- Germany – Pharmaceutical products – Generika Umweltfokus Nr. 1 (Bekanntmachung vergebener Aufträge) ↗Techniker Krankenkasseshared awardawarded 25 Sept 2025
- Germany – Pharmaceutical products – Ersatzkassen-Generika Nr. 25 (Bekanntmachung vergebener Aufträge) ↗Techniker Krankenkasseshared awardawarded 20 Sept 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Axitinib, ATC L01EK01 für die Zeit 01.09.2025 - 31.08.2027 (zzgl. Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 2 Sept 2025
- Anidulafungin 100 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung ↗Teilnehmende Gesundheitseinrichtungen der EKK plus GmbH€2kawarded 19 Aug 2025
- Germany – Antimycotics for systemic use – Antimykotika 2025 ↗Teilnehmende Gesundheitseinrichtungen der EKK plus GmbHshared awardawarded 7 Aug 2025
- Germany – Pharmaceutical products – 33. Generikaausschreibung (2;3er) Auftragsvergabe ↗GWQ ServicePlus AGshared awardawarded 8 Jul 2025
- Germany – Pharmaceutical products – 33. Generikaausschreibung (Sustainability) - Auftragsbekanntmachung ↗GWQ ServicePlus AGshared awardawarded 8 Jul 2025
- Germany – Pharmaceutical products – 33. Generikaausschreibung (1er) - Auftragsbekanntmachung ↗GWQ ServicePlus AGshared awardawarded 8 Jul 2025
- Germany – Pharmaceutical products – 33. Generikaausschreibung (Antibiotika) - Auftragsbekanntmachung ↗GWQ ServicePlus AGshared awardawarded 8 Jul 2025
- Desogestrel ↗GWQ ServicePlus AGshared awardawarded 7 Jul 2025
- Amoxicillin (FTA, TAB - EU) ↗GWQ ServicePlus AGshared awardawarded 7 Jul 2025
- Aclidinium bromid (IHP) ↗GWQ ServicePlus AGshared awardawarded 7 Jul 2025
- Bimatoprost + Timolol (MDO) ↗GWQ ServicePlus AGshared awardawarded 7 Jul 2025
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 3 Jul 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Denosumab, ATC M05BX04 für die Zeit 01.07.2025 - 30.06.2026 (zzgl. Verlängerungsoption 1x 12 Monate) ↗DAK-Gesundheitshared awardawarded 2 Jul 2025
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 4 Jun 2025
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 4 Jun 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Filgrastim, ATC L03AA02 für die Zeit 01.04.2024 - 31.03.2026 ↗DAK-Gesundheitshared awardawarded 2 Apr 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Erythropoietin ausschließlich Epoetin alfa, ATC B03XA01 für die Zeit 01.03.2025 - 28.02.2027 ↗DAK-Gesundheitshared awardawarded 1 Mar 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Pegfilgrastim, ATC L03AA13 für die Zeit 01.03.2025 - 28.02.2026 (zzgl. Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 1 Mar 2025
- Germany – Pharmaceutical products – 32. Generikaausschreibung (2;3er) - Auftragsvergabe ↗GWQ ServicePlus AGshared awardawarded 27 Jan 2025
- Aripiprazol (LSE) ↗GWQ ServicePlus AGshared awardawarded 27 Jan 2025
- Azelastin und Fluticason 17-propionat - TK, hkk, HEK (ATC-Code: R01AD28) ↗Techniker Krankenkasseshared awardawarded 23 Dec 2024
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
- Hexal AG (BG Hexal 1 A Pharma GbR)12 awards
- Hexal AG (BG ALIUD HEXAL Viatris GbR)4 awards
- Hexal AG (BG Glenmark Hexal GbR)3 awards
- Hexal AG (BG Hexal 1 A Pharma)2 awards
- Hexal AG (BG Zentiva/Aristo/Hexal GbR)2 awards
- Hexal AG (BG ALIUD HEXAL 1 A PHARMA GbR)1 award
- Hexal AG (BG ALIUD/Hexal/Mylan GbR)1 award
- Hexal AG (BG Aristo Hexal Zentiva GbR)1 award
- Hexal AG (BG TEVA/Hexal GbR)1 award
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.